API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
10
PharmaCompass offers a list of Butenafine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Butenafine manufacturer or Butenafine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Butenafine manufacturer or Butenafine supplier.
PharmaCompass also assists you with knowing the Butenafine API Price utilized in the formulation of products. Butenafine API Price is not always fixed or binding as the Butenafine Price is obtained through a variety of data sources. The Butenafine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Butenafine HCL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Butenafine HCL, including repackagers and relabelers. The FDA regulates Butenafine HCL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Butenafine HCL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Butenafine HCL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Butenafine HCL supplier is an individual or a company that provides Butenafine HCL active pharmaceutical ingredient (API) or Butenafine HCL finished formulations upon request. The Butenafine HCL suppliers may include Butenafine HCL API manufacturers, exporters, distributors and traders.
click here to find a list of Butenafine HCL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Butenafine HCL DMF (Drug Master File) is a document detailing the whole manufacturing process of Butenafine HCL active pharmaceutical ingredient (API) in detail. Different forms of Butenafine HCL DMFs exist exist since differing nations have different regulations, such as Butenafine HCL USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Butenafine HCL DMF submitted to regulatory agencies in the US is known as a USDMF. Butenafine HCL USDMF includes data on Butenafine HCL's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Butenafine HCL USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Butenafine HCL suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Butenafine HCL Drug Master File in Japan (Butenafine HCL JDMF) empowers Butenafine HCL API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Butenafine HCL JDMF during the approval evaluation for pharmaceutical products. At the time of Butenafine HCL JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Butenafine HCL suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Butenafine HCL Drug Master File in Korea (Butenafine HCL KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Butenafine HCL. The MFDS reviews the Butenafine HCL KDMF as part of the drug registration process and uses the information provided in the Butenafine HCL KDMF to evaluate the safety and efficacy of the drug.
After submitting a Butenafine HCL KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Butenafine HCL API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Butenafine HCL suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Butenafine HCL as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Butenafine HCL API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Butenafine HCL as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Butenafine HCL and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Butenafine HCL NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Butenafine HCL suppliers with NDC on PharmaCompass.
Butenafine HCL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Butenafine HCL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Butenafine HCL GMP manufacturer or Butenafine HCL GMP API supplier for your needs.
A Butenafine HCL CoA (Certificate of Analysis) is a formal document that attests to Butenafine HCL's compliance with Butenafine HCL specifications and serves as a tool for batch-level quality control.
Butenafine HCL CoA mostly includes findings from lab analyses of a specific batch. For each Butenafine HCL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Butenafine HCL may be tested according to a variety of international standards, such as European Pharmacopoeia (Butenafine HCL EP), Butenafine HCL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Butenafine HCL USP).